Indian pharma CEOs bet big on innovation to achieve US $130 bn
While industry steps out of its comfort zone to innovate, the government has to support by allocating funds across research lifecycle and offer incentives for innovation
While industry steps out of its comfort zone to innovate, the government has to support by allocating funds across research lifecycle and offer incentives for innovation
It is anticipated to be safe and efficacious by targeting the receptor-binding domain (RBD) of the new coronavirus
Diabetes has the highest prevalence and comorbidities among all NCD’s in India and it is mostly found among people in the south and east India
Thermo Fisher Scientific expands diagnostics portfolio to support full qPCR assay development and testing workflow
Its unique technology, ChetoSensar gives new promise to ADCs by alleviating solubility challenges
It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development
Assam is home to more than 1,700 species of medicinal plants
Coordinated and collaborative efforts will strongly contribute to the achievement of shared goals faster: Mandaviya
The funds will be used to buy medicines, enhance oxygen supply and augment the bed capacity in the local and district level hospitals
India’s dependency on China for pharma intermediates can change if there is a proper coordination between educational institutes, research institutes and pharma manufacturers
Subscribe To Our Newsletter & Stay Updated